Wiedemann Julia, Paruchuru Sai K, den Boef Lisette E, Brouwer Uilke, Silljé Herman H W, Schouten Elisabeth M, Dickinson Michael G, van Goethem Marc-Jan, Coppes Robert P, van Luijk Peter
Departments of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Biomedical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Departments of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):191-201. doi: 10.1016/j.ijrobp.2024.07.2330. Epub 2024 Aug 15.
When irradiating thoracic tumors, dose to the heart or lung has been associated with survival. We previously showed in a rat model that in addition to known side effects such as pericarditis, pneumonitis and fibrosis, heart and/or lung irradiation also impaired diastolic function and increased pulmonary artery pressure. Simultaneous irradiation of both organs strongly intensified these effects. However, the long-term consequences of these interactions are not yet known. Therefore, here, we investigated the long-term effects of combined heart and lung irradiation.
Different regions of the rat thorax containing the heart and/or 50% of the lungs were irradiated with protons. Respiratory rate (RR) was measured biweekly as an overall parameter for cardiopulmonary function. Echocardiography of the heart was performed at 8, 26, and 42 weeks after irradiation. Tissue remodeling and vascular changes were assessed using Masson trichrome and Verhoeff-stained lung and left ventricle tissue collected at 8 and 42 weeks after irradiation.
During the entire experimental period RR was consistently increased after combined heart/lung irradiation. This coincided with persistent effects on lung vasculature and reduced right-ventricle (RV) contraction. In contrast, recovery of RR, pulmonary remodeling and RV contraction was observed after sparing of the heart. These corresponding temporal patterns suggest that the reduction of RV function is related to vascular remodeling in the lung.
Combined irradiation of lung and heart leads to an intensified, persistent reduction of cardiopulmonary function. Recovery of the pulmonary vasculature and RV function requires heart sparing.
在对胸部肿瘤进行放射治疗时,心脏或肺部所接受的剂量与生存率相关。我们之前在大鼠模型中发现,除了心包炎、肺炎和纤维化等已知的副作用外,心脏和/或肺部照射还会损害舒张功能并增加肺动脉压力。同时对这两个器官进行照射会强烈加剧这些影响。然而,这些相互作用的长期后果尚不清楚。因此,在本文中,我们研究了心脏和肺部联合照射的长期影响。
用质子对大鼠胸部包含心脏和/或50%肺组织的不同区域进行照射。每两周测量一次呼吸频率(RR),将其作为心肺功能的总体参数。在照射后8周、26周和42周对心脏进行超声心动图检查。使用Masson三色染色法和Verhoeff染色法对照射后8周和42周收集的肺组织和左心室组织进行组织重塑和血管变化评估。
在整个实验期间,心脏/肺部联合照射后RR持续升高。这与对肺血管系统的持续影响以及右心室(RV)收缩功能降低相吻合。相比之下,在心脏未受照射的情况下,观察到RR、肺重塑和RV收缩功能有所恢复。这些相应的时间模式表明,RV功能的降低与肺部血管重塑有关。
心脏和肺部联合照射会导致心肺功能持续且加剧的降低。肺血管系统和RV功能的恢复需要保护心脏。